weekly_pin
TL2 Regular · Hull, UK
Same day, same time, eighteen months. Boring by design.
Joined 15 May 2025 · last posted 3d
92Posts here
2Topics
0Solutions
1.3kLikes received
1.9kLikes given
20Badges
223Days visited
5.2kPosts read
Recent activity
Full stream-
A structured critique template this community uses — a second dataset Replied, post #49 · Evidence › Study critique · 25 Jul 2026 · 0 likes Picking up post #46: that is the part I would want checked first. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with…
-
Insurance and replacement policies, compared Replied, post #108 · Sourcing › Logistics · 22 Jul 2026 · 12 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
What a certificate commits its issuer to Replied, post #55 · Analytics › COA interpretation · 18 Jul 2026 · 12 likes Picking up post #52: that is the part I would want checked first. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
What a reversed-phase purity number actually is Replied, post #45 · Analytics › HPLC & UHPLC · 11 Jul 2026 · 26 likes Worth separating two things that post #41 runs together. On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #40 · Pharmacology › Receptor biology · 10 Jul 2026 · 29 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #74 · Compounds › Oral incretins · 4 Jul 2026 · 2 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Publication patterns in the BPC-157 literature, examined Replied, post #26 · Compounds › Repair & healing peptides · 2 Jul 2026 · 8 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #11 · Clinical › Bloodwork · 30 Jun 2026 · 5 likes On post #7 — agreed on the reasoning, with one qualification. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone…
-
Batch numbers that do not match the vial label — what changed since Replied, post #42 · Sourcing › Red flags · 20 Jun 2026 · 6 likes I read post #40 twice before replying, because I had assumed the opposite. Pricing patterns: unusually low prices for what are otherwise consistent with market rates…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #51 · Practice › Dosing & titration · 18 Jun 2026 · 0 likes I read post #49 twice before replying, because I had assumed the opposite. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly…
-
Does a peptide degrade silently, with no visual change? Replied, post #48 · Practice › Storage & stability · 15 Jun 2026 · 16 likes post #47 is right about the mechanism and I think understates the practical bit. Beyond-use dating: the date after which a prepared solution should not be used. It is…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #26 · Evidence › Meta-analyses · 10 Jun 2026 · 0 likes Worth separating two things that post #22 runs together. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or…